protein

Recombinant Human Creatine Kinase MB Isoenzyme Type-2

MBS142066

0.01 mg

140 USD

Recombinant Protein

Recombinant Human Creatine Kinase MB Isoenzyme Type-2

Creatine Kinase MB Isoenzyme Type-2

CKMBITII Human; Creatine Kinase MB Isoenzyme Type-II Human Recombinant; Creatine Kinase MB Isoenzyme Type-II; CKMBITII; CKMBI; CKMB; CKMB Type-2

CKMB

Pichia Pastoris

Greater than 95.0% as determined by: (a) Analysis by RP-HPLC. (b) Analysis by SDS-PAGE.

Each mg of protein contains 20mM Tris-HCl, pH-6.8, 1mM EDTA and 1mM DTT, 50% (v/v) glycerol. Sterile Filtered colourless liquid formulation.

CKMBITII although stable at 15 degree C for 7 days, should be stored below -18 degree C. Please prevent freeze-thaw cycles.

Biological Activity: The biological activity measured by the enzymatic activity of Creatine phosphokinase procedure No.45-UV, 1IU-1 umole creatine phosphate was 892 IU/mg at 37 degrees Celsius, corresponding to a Specific Activity of 1,171ng/ml.

PROTEIN KINASES; Enzymes; Creatin Kinases

Description: CKMBITII Human Recombinant produced in Pichia Pastoris is a glycosylated polypeptide chain having an identical amino acid sequence compared to the native enzyme, purified under non-denaturing conditions and reacts with polyclonal antibodies to MB Isoenzyme in ELISA.The CKMBITII is purified by proprietary chromatographic techniques. Introduction: CK-MB Type II possesses the naturally occurring carboxy-terminal amino acid lysine.This occurs during a myocardial infarct (MI or heart attack) when CK-MB Type II is released from damaged heart muscle, and the C-terminal lysine is cleaved in the blood stream, thus creating CK-MB Type I. This difference can be exploited in diagnosis of an MI.

0.01 mg

140 USD

0.05 mg

205

1 mg

1220